BBGBloomberg·2hBusiness
score+0.70
Chiesi Agrees to Buy KalVista Pharmaceuticals for $1.9 Billion
Original
Chiesi Agrees to Buy KalVista Pharmaceuticals for $1.9 Billion
“Acquisition framed as expansion success with record investment milestone and strategic portfolio growth.”